{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:15Z","timestamp":1787002335309,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:00:00Z","timestamp":1426636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/ejhg.2015.47","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T08:54:13Z","timestamp":1426668853000},"page":"1665-1672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2"],"prefix":"10.1038","volume":"23","author":[{"given":"David J","family":"Kwiatkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"Jozwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"key":"BFejhg201547_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/9783527630073","volume-title":"Tuberous Sclerosis Complex","author":"DJ Kwiatkowski","year":"2010","unstructured":"Kwiatkowski DJ, Thiele EA, Whittemore VH : Tuberous Sclerosis Complex. Weinheim, Germany: Wiley-VCH, 2010."},{"key":"BFejhg201547_CR2","first-page":"161","volume-title":"Tuberous Sclerosis Complex: From Genes to Therapeutics","author":"P Crino","year":"2010","unstructured":"Crino P, Mehta R, Vinters HV : Pathogenesis of TSC in the brain; in: Kwiatkowski DJ, Whittemore VH, Thiele EA (eds): Tuberous Sclerosis Complex: From Genes to Therapeutics. Berlin: Wiley-VCH, 2010, pp 161\u2013185."},{"key":"BFejhg201547_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/9783527630073.ch11","volume-title":"Tuberous Sclerosis Complex","author":"DN Franz","year":"2010","unstructured":"Franz DN, Krueger DA, Balko MG : Subependymal giant cell astrocytomas; in: Kwiatkowski DJ, Whittemore VH, Thiele EA (eds): Tuberous Sclerosis Complex. Weinheim, Germany: Wiley-VCH, 2010, pp 211\u2013228."},{"key":"BFejhg201547_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2013.12.004","volume":"50","author":"K Kotulska","year":"2014","unstructured":"Kotulska K, Borkowska J, Roszkowski M et al: Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol 2014; 50: 307\u2013312.","journal-title":"Pediatr Neurol"},{"key":"BFejhg201547_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-2006-950391","volume":"49","author":"NB Levine","year":"2006","unstructured":"Levine NB, Collins J, Franz DN, Crone KR : Gradual formation of an operative corridor by balloon dilation for resection of subependymal giant cell astrocytomas in children with tuberous sclerosis: specialized minimal access technique of balloon dilation. Minim Invas Neurosurg 2006; 49: 317\u2013320.","journal-title":"Minim Invas Neurosurg"},{"key":"BFejhg201547_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.20784","volume":"59","author":"DN Franz","year":"2006","unstructured":"Franz DN, Leonard J, Tudor C et al: Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006; 59: 490\u2013498,.","journal-title":"Ann Neurol"},{"key":"BFejhg201547_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","volume":"80","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN : Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology 2013; 80: 574\u2013580.","journal-title":"Neurology"},{"key":"BFejhg201547_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejpn.2012.12.008","volume":"17","author":"S Jozwiak","year":"2013","unstructured":"Jozwiak S, Nabbout R, Curatolo P, participants of the TSCCMfS Epilepsy M : Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur J Paediatr Neurol 2013; 17: 348\u2013352.","journal-title":"Eur J Paediatr Neurol"},{"key":"BFejhg201547_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","volume":"49","author":"J Roth","year":"2013","unstructured":"Roth J, Roach ES, Bartels U et al: Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 2013; 49: 439\u2013444.","journal-title":"Pediatr Neurol"},{"key":"BFejhg201547_CR10","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1159\/000320891","volume":"118","author":"BP Dixon","year":"2011","unstructured":"Dixon BP, Hulbert JC, Bissler JJ : Tuberous sclerosis complex renal disease. Nephron Exp Nephrol 2011; 118: e15\u2013e20.","journal-title":"Nephron Exp Nephrol"},{"key":"BFejhg201547_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","volume":"105","author":"P Sooriakumaran","year":"2010","unstructured":"Sooriakumaran P, Gibbs P, Coughlin G et al: Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 2010; 105: 101\u2013106.","journal-title":"BJU Int"},{"key":"BFejhg201547_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/9783527630073.ch15","volume-title":"Tuberous Sclerosis Complex","author":"J Bissler","year":"2010","unstructured":"Bissler J, Henske EP : Renal manifestations of tuberous sclerosis complex; in: Kwiatkowski DJ, Whittemore VH, Thiele EA (eds): Tuberous Sclerosis Complex. Weinheim, Germany: Wiley-VCH, 2010, pp 311\u2013326."},{"key":"BFejhg201547_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1086\/514888","volume":"61","author":"JR Sampson","year":"1997","unstructured":"Sampson JR, Maheshwar MM, Aspinwall R et al: Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997; 61: 843\u2013851.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201547_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1086\/301705","volume":"62","author":"K-S Au","year":"1998","unstructured":"Au K-S, Rodriguez JA, Finch JL et al: Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet 1998; 62: 286\u2013294.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201547_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1469-1809.1998.6230203.x","volume":"62","author":"JM Young","year":"1998","unstructured":"Young JM, Burley MW, Jeremiah SJ et al: A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients. Ann Hum Genet 1998; 62: 203\u2013213.","journal-title":"Ann Hum Genet"},{"key":"BFejhg201547_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s100380050185","volume":"44","author":"H Zhang","year":"1999","unstructured":"Zhang H, Nanba E, Yamamoto T et al: Mutational analysis of TSC1 and TSC2 genes in Japanese patients with tuberous sclerosis complex. J Hum Genet 1999; 44: 391\u2013396.","journal-title":"J Hum Genet"},{"key":"BFejhg201547_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<401::AID-HUMU6>3.0.CO;2-R","volume":"14","author":"K Mayer","year":"1999","unstructured":"Mayer K, Ballhausen W, Rott HD : Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects. Hum Mutat 1999; 14: 401\u2013411.","journal-title":"Hum Mutat"},{"key":"BFejhg201547_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K","volume":"14","author":"Y Niida","year":"1999","unstructured":"Niida Y, Lawrence-Smith N, Banwell A et al: Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 1999; 14: 412\u2013422.","journal-title":"Hum Mutat"},{"key":"BFejhg201547_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW et al: Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999; 64: 1305\u20131315.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201547_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jmg.36.4.285","volume":"36","author":"M van Slegtenhorst","year":"1999","unstructured":"van Slegtenhorst M, Verhoef S, Tempelaars A et al: Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype\u2013phenotype correlation. J Med Genet 1999; 36: 285\u2013289.","journal-title":"J Med Genet"},{"key":"BFejhg201547_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/(SICI)1096-8628(20000117)90:2<123::AID-AJMG7>3.0.CO;2-L","volume":"90","author":"Y Yamashita","year":"2000","unstructured":"Yamashita Y, Ono J, Okada S et al: Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: report of 10 mutations. Am J Med Genet 2000; 90: 123\u2013126.","journal-title":"Am J Med Genet"},{"key":"BFejhg201547_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of tsc2, compared with tsc1, disease in multiple organs. Am J Hum Genet 2001; 68: 64\u201380.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201547_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00431-001-0903-7","volume":"161","author":"N Langkau","year":"2002","unstructured":"Langkau N, Martin N, Brandt R et al: TSC1 and TSC2 mutations in tuberous sclerosis, the associated phenotypes and a model to explain observed TSC1\/TSC2 frequency ratios. Eur J Pediatr 2002; 161: 393\u2013402.","journal-title":"Eur J Pediatr"},{"key":"BFejhg201547_CR24","first-page":"1","volume":"45","author":"A Apak","year":"2003","unstructured":"Apak A, Haliloglu G, Kose G, Yilmaz E, Anlar B, Aysun S : Mutation analysis of TSC2 gene in 33 Turkish familial cases with tuberous sclerosis. Turk J Pediatr 2003; 45: 1\u20135.","journal-title":"Turk J Pediatr"},{"key":"BFejhg201547_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/humu.20227","volume":"26","author":"ND Rendtorff","year":"2005","unstructured":"Rendtorff ND, Bjerregaard B, Frodin M et al: Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1\/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations. Hum Mutat 2005; 26: 374\u2013383.","journal-title":"Hum Mutat"},{"key":"BFejhg201547_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak O, Nellist M, Goedbloed M et al: Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype - phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005; 13: 731\u2013741.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201547_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0404.2004.00366.x","volume":"111","author":"M Ali","year":"2005","unstructured":"Ali M, Girimaji SC, Markandaya M, Shukla AK, Sacchidanand S, Kumar A : Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex. Acta Neurol Scand 2005; 111: 54\u201363.","journal-title":"Acta Neurol Scand"},{"key":"BFejhg201547_CR28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.braindev.2006.01.006","volume":"28","author":"JE Choi","year":"2006","unstructured":"Choi JE, Chae JH, Hwang YS, Kim KJ : Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex. Brain Dev 2006; 28: 440\u2013446.","journal-title":"Brain Dev"},{"key":"BFejhg201547_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2350-7-72","volume":"7","author":"CC Hung","year":"2006","unstructured":"Hung CC, Su YN, Chien SC et al: Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. BMC Med Genet 2006; 7: 72.","journal-title":"BMC Med Genet"},{"key":"BFejhg201547_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00439-006-0308-9","volume":"121","author":"P Kozlowski","year":"2007","unstructured":"Kozlowski P, Roberts P, Dabora S et al: Identification of 54 large deletions\/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 2007; 121: 389\u2013400.","journal-title":"Hum Genet"},{"key":"BFejhg201547_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au KS, Williams AT, Roach ES et al: Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007; 9: 88\u2013100.","journal-title":"Genet Med"},{"key":"BFejhg201547_CR32","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000280578.99900.96","volume":"70","author":"FE Jansen","year":"2008","unstructured":"Jansen FE, Braams O, Vincken KL et al: Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 2008; 70: 908\u2013915.","journal-title":"Neurology"},{"key":"BFejhg201547_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/9783527630073","volume-title":"Tuberous Sclerosis Complex","author":"DJ Kwiatkowski","year":"2010","unstructured":"Kwiatkowski DJ : Genetics of tuberous sclerosis complex; in: Kwiatkowski DJ, Whittemore VH, Thiele EA (eds): Tuberous Sclerosis Complex. Weinheim, Germany: Wiley-VCH, 2010, pp 29\u201360."},{"key":"BFejhg201547_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S et al: Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013; 381: 125\u2013132.","journal-title":"Lancet"},{"key":"BFejhg201547_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al: Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013; 381: 817\u2013824.","journal-title":"Lancet"},{"key":"BFejhg201547_CR36","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","volume":"89","author":"S Henikoff","year":"1992","unstructured":"Henikoff S, Henikoff JG : Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci USA 1992; 89: 10915\u201310919.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg201547_CR37","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","volume":"6","author":"AC Jones","year":"1997","unstructured":"Jones AC, Daniells CE, Snell RG et al: Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 1997; 6: 2155\u20132161.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201547_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR et al: Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140\u2013151.","journal-title":"N Engl J Med"},{"key":"BFejhg201547_CR39","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger DA, Care MM, Holland K et al: Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010; 363: 1801\u20131811.","journal-title":"N Engl J Med"},{"key":"BFejhg201547_CR40","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J et al: Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364: 1595\u20131606.","journal-title":"N Engl J Med"},{"key":"BFejhg201547_CR41","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","volume":"17","author":"DM Davies","year":"2011","unstructured":"Davies DM, de Vries PJ, Johnson SR et al: Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res 2011; 17: 4071\u20134081.","journal-title":"Clin Cancer Res"},{"key":"BFejhg201547_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/01.WNL.0000073272.47681.BB","volume":"61","author":"SE O'Connor","year":"2003","unstructured":"O'Connor SE, Kwiatkowski DJ, Roberts PS, Wollmann RL, Huttenlocher PR : A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology 2003; 61: 409\u2013412.","journal-title":"Neurology"},{"key":"BFejhg201547_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1399-0004.2011.01648.x","volume":"81","author":"M Wentink","year":"2012","unstructured":"Wentink M, Nellist M, Hoogeveen-Westerveld M et al: Functional characterization of the TSC2 c.3598C&gt;T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds. Clin Genet 2012; 81: 453\u2013461.","journal-title":"Clin Genet"},{"key":"BFejhg201547_CR44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ana.21037","volume":"60","author":"AC Jansen","year":"2006","unstructured":"Jansen AC, Sancak O, D'Agostino MD et al: Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol 2006; 60: 528\u2013539.","journal-title":"Ann Neurol"},{"key":"BFejhg201547_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM199903043400905","volume":"340","author":"J Kwiatkowska","year":"1999","unstructured":"Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski DJ : Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999; 340: 703\u2013707.","journal-title":"N Engl J Med"},{"key":"BFejhg201547_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00439-010-0801-z","volume":"127","author":"W Qin","year":"2010","unstructured":"Qin W, Kozlowski P, Taillon BE et al: Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex. Hum Genet 2010; 127: 573\u2013582.","journal-title":"Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201547","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T17:31:32Z","timestamp":1691515892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,18]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFejhg201547"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2015.47","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,18]]},"assertion":[{"value":"16 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DJK has served as consultant to Novartis and received support with the data analysis and writing of this manuscript. SJ has received honoraria from Novartis. JB has received research support from Novartis. DNF has received support for other research at his institution from Novartis; has served as consultant to Novartis (payments to his employer CCHMC); has received honoraria from Novartis and Lundbeck Pharmaceuticals; has been reimbursed by Novartis and Lundbeck Pharmaceuticals for travel costs for lectures; has performed legal work in reviewing medical malpractice cases and occasionally in giving expert testimony for various attorneys. SS has received honoraria from Novartis and Lundbeck Pharmaceuticals. MRP and DC are employees and shock holders of Novartis. JRS has received honoraria and research support from Novartis","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}